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Unfortunately, the original version of Figs. 4, 5 and 6b in
the article [1] contained errors in the n numbers as indi-
cated on the columns. Please note that column heights
and error bars in the original figures and data in the
ESM tables are correct and statistical tests are valid.
These corrections do not affect any results or conclu-
sions in this article.
The correct n numbers are as follows:
Figure 4 (http://media.springernature.com/full/springer-
static/image/art%3A10.1186%2Fs13550-016-0218-3/Media
Objects/13550_2016_218_Fig4_HTML.gif): ‘HCT116’ (IC)
n = 8; ‘A549’ (WWU) n = 7; ‘HCT116’ (WMIC) n = 3;
‘H1975’ (AZ) n = 6.
Figure 5 (http://media.springernature.com/full/springer-
static/image/art%3A10.1186%2Fs13550-016-0218-3/Media
Objects/13550_2016_218_Fig5_HTML.gif): ‘ONU (AZ)’
n = 6; ‘H1975 in ONU (AZ)’ n = 6; ‘A431 in ONU (AZ)’
n = 6.
Figure 6b (http://media.springernature.com/full/springer-
static/image/art%3A10.1186%2Fs13550-016-0218-3/Media
Objects/13550_2016_218_Fig6_HTML.gif): ‘PC9’ n = 13.
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